Skip to content

Clinical trials

Completed Dermatitis, Atopic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Status: Completed Country / region: South Korea Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20132
20143
20154
20166
20173
20188
20192
20205
20212
20223
20235
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Amgen5
Pfizer5
AbbVie4
Amorepacific Corporation3
Regeneron Pharmaceuticals3
Shaperon3
EHL Bio Co., Ltd.2
Kang Stem Biotech Co., Ltd.2
LEO Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic48
Eczema11
Skin Diseases5
Dermatitis4
Hypersensitivity2
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Asthma1
Genetic Diseases, Inborn1
Hypersensitivity, Immediate1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.